Erleada

Indicated For

non-metastatic castration-resistant prostate cancer, metastatic castration-sensitive prostate cancer

About This Medication

# Janssen Patient Assistance Program Patient Guide: How to Get **Erleada (apalutamide)** at Low or No Cost Erleada (apalutamide) is a prescription medication used to treat certain types of prostate cancer, such as non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). The **Janssen Patient Assistance Program** helps eligible patients in the United States receive Erleada at no cost if they meet income and insurance requirements.[1][2][9] ## About Erleada and Why Assistance Matters **Erleada**, known generically as apalutamide, is an androgen receptor inhibitor that helps slow the growth of prostate cancer cells by blocking male hormones from fueling the cancer. It's typically taken as oral capsules once daily. Prostate cancer treatments like Erleada can be expensive, often costing thousands of dollars per month without assistance. This program bridges the gap for patients who can't fully afford it despite having some insurance coverage.[1][2] High drug costs can lead to treatment delays or skipping doses, which is dangerous for cancer patients. The Janssen program ensures eligible individuals get their medication shipped directly to them or their doctor's office, easing financial stress so you can focus on your health.[1][9] ## Who Qualifies for the Program? To qualify, you must: - Live in the United States or a U.S. territory. - Be treated as an outpatient by a U.S.-licensed healthcare provider. - Have a prescription for Erleada (an eligible Janssen medication). - Meet income eligibility requirements (specific thresholds determined by Janssen based on household size and income). - Have commercial, employer-sponsored, or government insurance that does not fully cover your needs (e.g., high copays or deductibles).[1][2][3] **Medicare Part D patients** have extra rules: You must spend more than 4% of your gross annual household income on prescription drugs and, if your income is ≤150% of the Federal Poverty Level (FPL), demonstrate you're not eligible for Low-Income Subsidy (LIS).[2][3] Uninsured patients may qualify if they've checked eligibility for free or low-cost insurance options. The program does not cover patients with fully adequate coverage or those who don't meet income guidelines.[1][2] ## Income Eligibility Breakdown Janssen reviews income on a case-by-case basis, often using your most recent Federal tax return (1040 or 1040-SR). There's no fixed FPL percentage listed publicly, but eligibility ties to household income relative to drug costs and insurance gaps. For Medicare patients, spending >4% of gross household income on prescriptions is key.[2][3] Here's a simplified overview (contact Janssen for your exact eligibility): | Household Size | Typical Income Consideration | Notes | |---------------|------------------------------|-------| | Individual | Reviewed case-by-case | Proof via tax return required[1] | | Couple | Reviewed case-by-case | Household income total[2] | | Family of 3 | Reviewed case-by-case | Include all dependents[1] | | Family of 4+ | Reviewed case-by-case | Larger families may have higher thresholds[3] | Always provide accurate income proof to avoid delays. Income changes must be reported within 30 days.[1][8] ## Insurance Requirements You need **commercial, employer-sponsored, or government coverage** (like Medicare Part D) that doesn't fully meet your needs—such as high out-of-pocket costs. Fully insured patients or those with no coverage attempts don't qualify. Submit front/back copies of insurance cards. Medicare patients: Provide a pharmacy report or Explanation of Benefits (EOB) showing yearly out-of-pocket drug costs.[1][2][3] If uninsured, certify you've applied for all free/low-cost options. The program coordinates with your insurer to verify coverage gaps.[1] ## Step-by-Step Application Process 1. **Download the Form**: Get the Patient Assistance Enrollment Form from JJPatientAssistance.com or the J&J withMe portal.[1][4] 2. **Complete Patient Sections**: Fill pages 2-5 with your info, including Patient Authorization. Review and sign Terms & Conditions on pages 4-7.[1][2] 3. **Gather Documents**: - Proof of income (recent 1040/1040-SR). - Proof of residency (e.g., utility bill). - Proof of insurance (cards front/back; EOB for Medicare). - Doctor-signed prescription info.[1][2] 4. **Healthcare Provider Completes Their Part**: Starting page 6, your doctor verifies prescription and eligibility.[1] 5. **Submit**: Fax to 1-833-512-0497, upload via the Document Upload Site, or mail. Call (833) 742-0791 for help (Mon-Fri, 8 AM-8 PM ET).[1][4] 6. **Wait for Review**: Janssen assesses insurance, income, and matches you to the right program. They'll update you and your doctor.[2] Applications with missing info delay processing—double-check everything![1] ## Timeline and Delivery Processing time isn't specified but aims to be prompt; incomplete apps cause delays. Once approved, medication ships free to your home or doctor's office. Coverage lasts up to one year, with **reauthorization required** annually or upon changes.[1][9] Expect status updates via phone/email. You can check in at (833) 742-0791.[1] ## Alternatives if Denied or No Eligibility - **Janssen CarePath Savings Program**: For commercially insured patients; visit MyJanssenCarePath.com.[5] - **State Assistance**: Check your state's pharmaceutical aid programs. - **Low-Income Subsidy (LIS)**: For Medicare patients near 150% FPL.[3] - **Other Foundations**: PAN Foundation or CancerCare for prostate cancer grants. - **Generic/Biosimilar Options**: None currently for apalutamide.[program data] Call Janssen to discuss denial reasons and reapply if circumstances change.[1] ## Important Disclaimer This guide is for informational purposes only and based on publicly available program details as of general knowledge. Eligibility rules can change—**always verify with Janssen at (833) 742-0791 or their site**. Not medical advice; consult your doctor for treatment decisions. Janssen may end participation anytime, and meds can't be sold/traded. Report insurance/income changes within 30 days.[1][8] (Word count: 1028)

Program information last verified: March 30, 2026